Corcept Therapeutics (CORT) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $117.51 +3.30%
Revenue Growth %: +56.0%
Financial Fact:
Basic and diluted net loss per share: 0.02
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +56.0%
Financial Fact:
Basic and diluted net loss per share: 0.02
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q2 EPS of $0.03, $0.02 better than the analyst estimate of $0.01. Revenue for the quarter came in at $19.7 million versus the consensus estimate of $18.36 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- Aytu BioScience (AYTU) Tops Q4 EPS by 28c
- Talos Energy closes $420M Gulf of America deepwater asset deal
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
